The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC).

Authors

• William Kelly

Publication/Presentation Date

5-2015

Volume

33

Issue

15

Published In/Presented At

DOI: 10.1200/jco.2015.33.15_suppl.5000

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article